Qlaris Bio is a clinical stage biotechnology company developing novel therapeutics for eye diseases.
peer of
investor of
Metrics
marketPRIVATE
msh_idBIO:QLARIS
websitehttps://qlaris.bio
source_ref0a7709ea-1afd-4e73-90f1-cd0699426b2d
products_or_servicesDevelopment of QLS-111, a lead asset designed to lower intraocular pressure (IOP) for the treatment of various eye conditions including Normal Tension Glaucoma, Primary Open-Angle Glaucoma, Ocular Hypertension, and elevated IOP associated with rare diseases such as Sturge-Weber Syndrome.